Edrecolomab
Edrecolomab (Panorex) is a murine monoclonal antibody to the cell-surface glycoprotein 17-1A, expressed on epithelial tissues and on various carcinomas. Edrecolomab shows anti-tumor activity and can be used in colorectal carcinoma research[1][2].
Product Specifications
CAS Number
[156586-89-9]
Product Name Alternative
Panorex; CO17-1A
UNSPSC
12352203
Target
Others
Type
Inhibitory Antibodies
Related Pathways
Others
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/edrecolomab.html
Purity
98.63
Solubility
10 mM in DMSO
Smiles
[Edrecolomab]
Molecular Weight
(144.5 kDa)
References & Citations
[1]Naundorf S, et al. In vitro and in vivo activity of MT201, a fully human monoclonal antibody for pancarcinoma treatment. Int J Cancer. 2002 Jul 1;100 (1) :101-10.|[2]Punt CJ, et al. Edrecolomab alone or in combination with fluorouracil and folinic acid in the adjuvant treatment of stage III colon cancer: a randomised study. Lancet. 2002 Aug 31;360 (9334) :671-7.
Shipping Conditions
Dry Ice
Storage Conditions
Store at -80°C for 2 years
Scientific Category
Inhibitory Antibodies
Clinical Information
Phase 3
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS1257081-01 0.02 mg (E-Coli)
Recombinant Bacillus cereus ATP synthase epsilon chain (atpC)
Ask
View Details 
MBS1257081-02 0.1 mg (E-Coli)
Recombinant Bacillus cereus ATP synthase epsilon chain (atpC)
Ask
View Details MBS1257081-03 0.02 mg (Yeast)
Recombinant Bacillus cereus ATP synthase epsilon chain (atpC)
Ask
View Details MBS1257081-04 0.1 mg (Yeast)
Recombinant Bacillus cereus ATP synthase epsilon chain (atpC)
Ask
View Details 
MBS1257081-05 0.02 mg (Baculovirus)
Recombinant Bacillus cereus ATP synthase epsilon chain (atpC)
Ask
View Details MBS1257081-06 0.02 mg (Mammalian-Cell)
Recombinant Bacillus cereus ATP synthase epsilon chain (atpC)
Ask
View Details